| Indicators | Browse All

Amarin Corporation plc (AMRN)

Healthcare | Drug Manufacturers - General | Dublin, Ireland | NasdaqCM
11.32 USD -0.25 (-2.161%) ⇩ (Oct. 16, 2026, 4 p.m. EDT)

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6:45 a.m. EDT

The investment case here is severely compromised by deteriorating fundamentals and a lack of income. The company is reporting negative profit margins and a sharp contraction in revenue growth, while the balance sheet shows negative free cash flow. Crucially, the long-term price trajectory tells a stark story of destruction; despite a recent year-over-year bounce, the asset has lost over 71% of its value over the last nine years, with six of the last seven years seeing declines. This multi-year structural decline suggests the market has permanently reassessed the business quality downward. There is no dividend to provide any cushion or yield, making the stock purely a capital appreciation play on a business that is currently bleeding money. While the recent year-over-year gain offers a glimmer of hope, it does not offset the overwhelming evidence of long-term value erosion. On the short end, options flow is mixed but leans defensive, with significant put buying at lower strikes, which aligns with the weak statistical forecast. Until the revenue decline halts and turns into sustained growth, this remains a high-risk speculative vehicle rather than a viable investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.036426
MSTL0.054754
AutoETS0.056007
AutoARIMA0.056007

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 40%
H-stat 28.23
Ljung-Box p 0.000
Jarque-Bera p 0.012
Excess Kurtosis -0.19
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.617
Revenue per Share 8.917
Market Cap 237,370,304
Forward P/E 11.55
Beta 0.77
Profit Margins -14.56%
Website https://www.amarincorp.com

As of Oct. 10, 2026, 6:45 a.m. EDT: Speculators are positioning defensively with heavy put volume and open interest concentrated in-the-money strikes (11.0 and 12.0), suggesting a fear of further downside. Conversely, call activity is skewed toward out-of-the-money strikes (15.0 and 19.0), indicating speculative bets on a rebound to previous highs rather than immediate near-term gains. Implied volatility is elevated on both sides, reflecting uncertainty.


Info Dump

Attribute Value
52 Week Change -0.44098765
Address1 One Central Plaza
Address2 8th Floor 36 Dame Street
All Time High 28,500.0
All Time Low 7.0
Ask 12.94
Ask Size 1
Average Daily Volume10 Day 74,810
Average Daily Volume3 Month 66,710
Average Volume 66,710
Average Volume10Days 74,810
Beta 0.768
Bid 9.8
Bid Size 1
Book Value 21.122
City Dublin
Compensation As Of Epoch Date 1,767,139,200
Country Ireland
Crypto Tradeable 0
Currency USD
Current Price 11.32
Current Ratio 3.671
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 11.575
Day Low 11.25
Debt To Equity 1.617
Display Name Amarin
Dividend Yield 0.0
Earnings Call Timestamp End 1,785,326,400
Earnings Call Timestamp Start 1,785,326,400
Earnings Timestamp 1,785,328,200
Earnings Timestamp End 1,793,190,600
Earnings Timestamp Start 1,793,190,600
Ebitda -21,095,000
Ebitda Margins -0.11327
Enterprise To Ebitda 3.241
Enterprise To Revenue -0.367
Enterprise Value -68,363,520
Eps Forward 0.98
Eps Trailing Twelve Months -1.2
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 13.4042
Fifty Day Average Change -2.0842
Fifty Day Average Change Percent -0.15548858
Fifty Two Week Change Percent -44.098766
Fifty Two Week High 20.9
Fifty Two Week High Change -9.58
Fifty Two Week High Change Percent -0.45837322
Fifty Two Week Low 11.25
Fifty Two Week Low Change 0.069999695
Fifty Two Week Low Change Percent 0.006222195
Fifty Two Week Range 11.25 - 20.9
Financial Currency USD
First Trade Date Milliseconds 733,674,600,000
Float Shares 19,412,307
Forward Eps 0.98
Forward P E 11.55102
Free Cashflow -5,569,250
Full Exchange Name NasdaqCM
Full Time Employees 80
Fullday Change -0.2699995
Fullday Change Percent -2.3336172
Fullday Price 11.32
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.41956002
Gross Profits 78,136,000
Has Pre Post Market Data 1
Held Percent Insiders 0.37186
Held Percent Institutions 0.20775
Implied Shares Outstanding 20,969,109
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Ir Website http://investor.amarincorp.com/
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,744,329,600
Last Split Factor 1:20
Long Business Summary Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Long Name Amarin Corporation plc
Market us_market
Market Cap 237,370,304
Market State CLOSED
Max Age 86,400
Message Board Id finmb_407863
Most Recent Quarter 1,782,777,600
Net Income To Common -27,124,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 287,696,173
Number Of Analyst Opinions 2
Open 11.5001
Operating Cashflow 15,573,000
Operating Margins -0.28358
Payout Ratio 0.0
Peg Ratio 0.81
Phone 353 0 166 99020
Previous Close 11.57
Price Hint 2
Price To Book 0.5359341
Price To Sales Trailing12 Months 1.2745879
Profit Margins -0.14565
Quick Ratio 2.491
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.25
Regular Market Change Percent -2.16076
Regular Market Day High 11.575
Regular Market Day Low 11.25
Regular Market Day Range 11.25 - 11.575
Regular Market Open 11.5001
Regular Market Previous Close 11.57
Regular Market Price 11.32
Regular Market Time 1,792,180,801
Regular Market Volume 113,656
Return On Assets -0.023120001
Return On Equity -0.059710003
Revenue Growth -0.42
Revenue Per Share 8.917
Sand P52 Week Change 0.13723719
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 20,969,109
Shares Percent Shares Out 0.025
Shares Short 528,373
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 511,002
Short Name Amarin Corporation plc
Short Percent Of Float 0.0255
Short Ratio 10.31
Source Interval 15
Symbol AMRN
Target High Price 13.0
Target Low Price 12.0
Target Mean Price 12.5
Target Median Price 12.5
Total Cash 314,648,992
Total Cash Per Share 14.896
Total Debt 7,175,000
Total Revenue 186,232,992
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.2
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 14.44965
Two Hundred Day Average Change -3.12965
Two Hundred Day Average Change Percent -0.21659003
Type Disp Equity
Volume 113,656
Website https://www.amarincorp.com
Zip D02 K7K5